Suppr超能文献

氨苄西林三水合物混悬液在琥珀色塑料口服注射器中的稳定性。

Stability of ampicillin trihydrate suspension in amber plastic oral syringes.

作者信息

Sylvestri M F, Makoid M C

出版信息

Am J Hosp Pharm. 1986 Jun;43(6):1496-8.

PMID:3728487
Abstract

The stability of ampicillin trihydrate oral suspension stored in amber plastic oral syringes was studied. Commercially available ampicillin trihydrate powder for oral suspension was reconstituted according to manufacturer's instructions and drawn into 5-mL amber polypropylene plastic oral syringes. The syringes were divided into groups and stored at -20, 4, 25, 60, or 80 degrees C. Powder from two additional lots was similarly reconstituted and packaged and stored at 80 degrees C only to assess interlot variability. Immediately after reconstitution and at specified times during storage, three syringes at each storage temperature were removed and their contents analyzed for ampicillin trihydrate concentration by a spectrophotometric assay. Samples stored at frozen (-20 degrees C) or refrigerated (4 degrees C) temperature retained at least 90% of the initial ampicillin concentration throughout the 47-day study period. Samples stored at room temperature retained at least 90% of the initial ampicillin concentration for 30 days and exhibited an apparent zero-order degradation rate. Samples stored at heated temperatures (60 and 80 degrees C) exhibited an apparent first-order degradation process, with the concentration of ampicillin decreasing to less than 90% of initial concentration within two hours. Reconstituted ampicillin trihydrate powder for oral suspension is stable for at least 30 days when stored at room, refrigerated, or frozen temperature in the amber plastic oral syringes studied. The expiration dates recommended by the manufacturer for ampicillin trihydrate suspension stored in its original container can also be used for reconstituted suspension stored in these amber plastic syringes.

摘要

研究了储存在琥珀色塑料口服注射器中的三水合氨苄西林口服混悬液的稳定性。将市售的三水合氨苄西林口服混悬液粉末按照制造商的说明进行复溶,并吸入5毫升琥珀色聚丙烯塑料口服注射器中。将注射器分组并分别储存在-20℃、4℃、25℃、60℃或80℃。另外两个批次的粉末同样进行复溶、包装并仅储存在80℃,以评估批次间的变异性。复溶后立即以及在储存期间的特定时间,取出每个储存温度下的三个注射器,并通过分光光度法测定其内容物中三水合氨苄西林的浓度。在整个47天的研究期间,储存在冷冻(-20℃)或冷藏(4℃)温度下的样品至少保留了初始氨苄西林浓度的90%。储存在室温下的样品在30天内至少保留了初始氨苄西林浓度的90%,并呈现出明显的零级降解速率。储存在加热温度(60℃和80℃)下的样品呈现出明显的一级降解过程,氨苄西林浓度在两小时内降至初始浓度的90%以下。在所研究的琥珀色塑料口服注射器中,复溶后的三水合氨苄西林口服混悬液粉末在室温、冷藏或冷冻温度下储存时至少稳定30天。制造商推荐的储存在原装容器中的三水合氨苄西林混悬液的有效期也可用于储存在这些琥珀色塑料注射器中的复溶混悬液。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验